Similar articles

• Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.

  Prager MD, Baechtel FS, Ribble RJ, Ludden CM, Mehta JM. Prager MD, et al. Cancer Res. 1974 Dec;34(12):3203-9. Cancer Res. 1974. PMID: 4429949 No abstract available.
• Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.

  Simmons RL, Rios A. Simmons RL, et al. J Immunol. 1973 Dec;111(6):1820-5. J Immunol. 1973. PMID: 4750868 No abstract available.
• [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].

  Bratus' GG, Darchuk GF. Bratus' GG, et al. Eksp Onkol. 1989;11(3):35-8. Eksp Onkol. 1989. PMID: 2752940 Russian.
• Neuraminidase treated cells and their role in cancer immunotherapy.

  Simmons RL, Rios A. Simmons RL, et al. Birth Defects Orig Artic Ser. 1973 Mar;9(2):223-8. Birth Defects Orig Artic Ser. 1973. PMID: 4611534 Review. No abstract available.
• Immunogenicity of tumors alkylated with cyclohexyl-, benzyl-. or 2,4-dinitrophenylmethacrylate.

  Palmer WN, Swanson TL, Moore GE. Palmer WN, et al. Ann N Y Acad Sci. 1976;277(00):412-27. doi: 10.1111/j.1749-6632.1976.tb41718.x. Ann N Y Acad Sci. 1976. PMID: 826206 Review. No abstract available.